LABP
Landos Biopharma Inc

562
Loading...
Loading...
News
all
press releases
AbbVie Completes Acquisition of Landos Biopharma
AbbVie Completes Acquisition of Landos Biopharma AbbVie Completes Acquisition of Landos Biopharma PR Newswire NORTH CHICAGO, Ill., May 23, 2024 - Adds first-in-class investigational asset, NX-13, to...
PR Newswire·1y ago
News Placeholder
More News
News Placeholder
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Landos Biopharma, Inc. (NasdaqCM: LABP) to...
Business Wire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LABP, ADTH, MODN, SCX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LABP, ADTH, MODN, SCX SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LABP, ADTH, MODN, SCX PR Newswire NEW YORK, April 18, 2024 NEW...
PR Newswire·1y ago
News Placeholder
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT PR Newswire NEW YORK, April 9, 2024 NEW YORK, April...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA PR Newswire NEW YORK, April 5, 2024 NEW YORK, April...
PR Newswire·1y ago
News Placeholder
HC Wainwright Reiterates Neutral Rating for Landos Biopharma (NASDAQ:LABP)
Landos Biopharma (NASDAQ:LABP - Get Free Report)s stock had its "neutral" rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports...
Zolmax·1y ago
News Placeholder
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ADTH, LABP, FUSN
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Globe Newswire·1y ago
News Placeholder
Maintaining Hold Rating on Landos Biopharma Amid Acquisition by AbbVie and Limited Upside Potential
Landos Biopharma (LABP Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from...
TipRanks Financial Blog·1y ago
News Placeholder
Landos Biopharma just downgraded at H.C. Wainwright, here's why
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago

Latest LABP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.